Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal pethidine added to bupivacaine for appendectomy pain control
IRCT20241022063464N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of pethidine and bupivacaine in appendicitis (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoints: Pain control during appendectomy surgery and Prevention of visceral pain. Started Dec 2024; status: completed.
02
Drugs
pethidinebupivacaine
03
Conditions
appendicitis
Beyond the preview
Go deeper on IRCT20241022063464N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241022063464N1.